TOUS - ETF AI Analysis
Top Page
T. Rowe Price International Equity ETF (TOUS)
Rating:65Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries in Europe, Asia, and North America, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, and several other sectors, limiting reliance on any one part of the economy.
Supportive Asset Base and Recent Performance
The ETF manages over a billion dollars and has shown steady gains over the past month, three months, and year-to-date, suggesting healthy investor interest and recent momentum.
Negative Factors
Moderate Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term returns for buy-and-hold investors.
Concentration in Financials and Industrials
A large share of assets is in financial and industrial companies, which could hurt performance if these sectors face a downturn.
Mixed Performance Among Top Holdings
While some leading positions have delivered strong gains, others have been weak or slightly negative this year, creating uneven contribution to returns.
TOUS vs. SPDR S&P 500 ETF (SPY)
AUM1.33B
RegionDeveloped Markets
Expense Ratio0.50%
Beta0.74
IssuerT. Rowe Price
Inception DateJun 14, 2023
Dividend Yield1.71%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume319,302
30 Day Avg. Volume268,678
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.77Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering176
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TOUS Summary
The T. Rowe Price International Equity ETF (TOUS) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to capture the total international market rather than tracking a specific index. It holds companies from Japan, the UK, Europe, and more, across sectors like financials, industrials, and technology. Well-known holdings include ASML Holding and Unilever. Someone might invest in TOUS to diversify beyond U.S. stocks and tap into growth in both developed and emerging markets. A key risk is that international stocks can be volatile and are affected by currency swings and global economic conditions.
How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.
TOUS Top 10 Holdings
TOUS leans heavily on non-U.S. blue chips, with Europe and other developed markets doing most of the talking. ASML and Renesas have been key engines, rising over the past few months on chip and AI optimism, even if their very recent trading has been a bit choppy. TotalEnergies has quietly added fuel to returns with steadier gains. On the flip side, financials like UniCredit and insurers such as AXA have been lagging, while defensives like Roche and Unilever feel more like ballast than boosters right now.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.60% | $46.21M | €425.45B | 94.11% | 76 Outperform | |
| AstraZeneca | 2.66% | $34.22M | $311.06B | 44.19% | 80 Outperform | |
| Rolls-Royce Holdings | 1.66% | $21.33M | £95.97B | 82.42% | 71 Outperform | |
| UniCredit SpA | 1.54% | $19.81M | €94.10B | 63.35% | 75 Outperform | |
| TotalEnergies SE | 1.48% | $19.05M | €169.53B | 65.28% | 78 Outperform | |
| Renesas Electronics | 1.38% | $17.73M | ¥4.11T | 39.80% | 64 Neutral | |
| Roche Holding AG | 1.36% | $17.53M | $314.74B | 34.95% | 73 Outperform | |
| Unilever | 1.35% | $17.35M | £91.52B | ― | 72 Outperform | |
| Deutsche Telekom | 1.31% | $16.86M | €150.68B | -1.23% | 67 Neutral | |
| AXA SA | 1.19% | $15.34M | €83.01B | 10.76% | 75 Outperform |
TOUS Technical Analysis
Positive
―
Price Trends
36.02
Negative
35.16
Negative
33.82
Positive
Market Momentum
-0.33
Negative
50.04
Neutral
81.92
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.58, equal to the 50-day MA of 36.02, and equal to the 200-day MA of 33.82, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 50.04 is Neutral, neither overbought nor oversold. The STOCH value of 81.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TOUS.
TOUS Peer Comparison
Comparison Results
Performance Comparison
TOUS
T. Rowe Price International Equity ETF
35.04
8.04
29.78%
DIHP
Dimensional International High Profitability ETF
―
―
―
DFIS
Dimensional International Small Cap ETF
―
―
―
DISV
Dimensional International Small Cap Value ETF
―
―
―
CGIE
Capital Group International Equity ETF
―
―
―
AVIV
Avantis International Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents